Emeritus Professor Warren Tate FRSNZ CNZM
Professor Warren Tate has been an academic and researcher at the University of Otago in Dunedin, New Zealand spanning 55 years. He is a Fellow of the Royal Society of New Zealand, and internationally, a Fellow of the Alexander von Humboldt Foundation of Germany, and was an International Research Scholar of the Howard Hughes Medical Institute of the United States.
Professor Tate’s research currently has a strong interest in unexplained human diseases.
He works on mammalian memory and Alzheimer’s disease and the development of a potential therapeutic agent based on a natural neuroprotective brain protein, secreted amyloid precursor protein alpha. His most recent research programme initiated in 2012 has been on Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) focussing on preclinical studies with New Zealand patients to understand its biological basis. Professor Tate approaches research on ME/CFS through the dual lens of an affected family of 30 years and a biomedical researcher. He has found molecular signatures for the illness supporting its biological basis and has now shown the post-Covid fatigue syndrome cohort of Long COVID sufferers who have ongoing illness from SARS-CoV-2 infection have closely overlapping molecular signatures as found in ME/CFS. Most recently he has become involved in advocating for many ME/CFS patients in NZ who have had ongoing serious adverse reactions from the COVID vaccination campaign.